Juvent Health Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$1.3M
Juvent Health General Information
Description
Provider of clinically validated solutions designed to improve musculoskeletal health. The company's platform sends carefully calibrated mechanical energy waves up through the body and uses the science of low-magnitude mechanical impulses to safely exercise bones, muscles and joints, enabling patients suffering with osteoporosis to increase blood flow and naturally recover their bones and joints.
Contact Information
Primary Industry
Therapeutic Devices
Primary Office
- 9420 Ooltewah Industrial Drive
- Suite 1
- Ooltewah, TN 37363
- United States
+1 (423) 000-0000
Juvent Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 25-Jun-2014 | $1.3M | 00.00 | Completed | Generating Revenue/Not Profitable |
Juvent Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of clinically validated solutions designed to improve musculoskeletal health. The company's platform sends care
Therapeutic Devices
Ooltewah, TN
5
As of 2017
00.00
0000000000
00.00
00000
iusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exe
00000 00000000 00000000
Northbrook, IL
0000
000000&0
Add Comparison
Juvent Health Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000 00000 00000 | Corporate Backed or Acquired | Northbrook, IL | 0000 | 000000&0 |
Juvent Health Patents
Juvent Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2733553-A1 | Local anti-infective agent for treatment of nail fungal infections | Abandoned | 13-Aug-2008 | 00000000 | |
| CA-2730806-A1 | Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic | Abandoned | 16-Jul-2008 | 0000000000 | |
| US-20090192125-A1 | Local anti-infective agent for treatment of nail fungal infections | Abandoned | 08-Feb-2007 | 00000000 | |
| US-20080193508-A1 | Topical formulation of omadine, octanoic acid, sorbic acid, hexanoic acid, or benzoic acid and 5-fluorocystine or terbinafine in a lacquer, a gel, a patch, or a hydrating system | Abandoned | 08-Feb-2007 | 0000000000 | |
| US-20090048347-A1 | Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic | Granted | 16-Jan-2007 | A61K9/0019 |
Juvent Health Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rush Simonson | Chairman & Chief Executive Officer | ||
| Peter Simonson | President and Board Member |
Juvent Health Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Peter Simonson | Juvent Health | President and Board Member | 000 0000 |
| Rush Simonson | Juvent Health | Chairman & Chief Executive Officer | 000 0000 |
Juvent Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
